POP-21 Estudio del potencial antidiabético y antiobesidad de las hojas de Neurolaena lobata (Asteraceae)
DOI:
https://doi.org/10.3407/rpn.v5i2.6859Palabras clave:
Asteraceae, α-glucosidasa, lipasa pancreática, neurolenina BResumen
Uno de los principales retos a nivel terapéutico para el siglo XXI está relacionado con la búsqueda de tratamientos para la diabetes tipo 2 y la obesidad.
Referencias
. Martinez-Gonzalez, A. I., Alvarez-Parrilla, E., Díaz-Sánchez, Á. G., de la Rosa, L. A., Núñez-Gastélum, J. A., Vazquez-Flores, A. A., & Gonzalez-Aguilar, G. A. (2017). In vitro inhibition of pancreatic lipase by polyphenols: A kinetic, fluorescence spectroscopy and molecular docking study. Food technology and biotechnology, 55(4), 519.
. Yung-Chi, C., & Prusoff, W. H. (1973). Relationship between the inhibition constant (KI) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction. Biochemical pharmacology, 22(23), 3099-3108.
. Jeon, W. S., & Park, C. Y. (2014). Antiobesity pharmacotherapy for patients with type 2 diabetes: focus on long-term management. Endocrinology and Metabolism, 29(4), 410-417.
. Yun, J. W. (2010). Possible anti-obesity therapeutics from nature–A review. phytochemistry, 71(14-15), 1625-1641
